DHPA joined a coalition of 240 patient and provider groups signing onto a letter to U.S. Senate and U.S. House leaders asking them to urge the Centers for Medicare & Medicaid Services (CMS) to reconsider a proposal to allow Medicare Advantage plans to implement step therapy to manage Part B drugs. CMS originally announced the […]
Continue Reading >>
DHPA Joins Coalition Opposing Payment Proposals in MPFS FY2019
DHPA joined the Patient-Centered Evaluation and Management Services Coalition in sending a letter to Centers for Medicare and Medicaid Services (CMS) and Congressional leadership supporting CMS’s proposed simplification of documentation requirements and opposing implementation of proposed payment changes in the Medicare Physician Fee Schedule Proposed Rule for Calendar Year 2019. In the letters, the Coalition […]
Continue Reading >>
DHPA Submits Comments on CMS Request for Information on the Stark Law
The Digestive Health Physicians Association has submitted a comment letter in response to the Centers for Medicare & Medicaid Services’ Request for Information on the Physician Self-Referral (Stark) law. DHPA is committed to ensuring that independent GI practices across the country can participate in alternative payment models (APMs) and other novel financial arrangements that deliver […]
Continue Reading >>
DHPA Submits Comments in Response to HHS RFI on “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs”
DHPA has submitted comments to the U.S. Health and Human Services Request for Information entitled “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.” In the comment letter, DHPA focuses on several of the key initiatives highlighted in the RFI: DHPA supports site neutrality for physician-administered drugs across the hospital and independent physician practice settings […]
Continue Reading >>
DHPA Urges Administration to Reject Proposals That Could Impact Access and Affordability for Part B Medications
DHPA joined with 215 advocacy groups to voice concern about Medicare Part B proposals outlined in President Trump’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs and corresponding Request for Information (RFI) that could have harmful consequences for patients with serious diseases. In a letter to HHS Secretary Alex Azar, the groups wrote, “As […]
Continue Reading >>
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 19
- Next Page »